Chemotherapy and the life cycle of leukaemic cells. A comparison between the growth characteristics of human acute leukaemia and the murine leukaemia L 1210.
D000813:Anilides / Q000627:therapeutic use; D000818:Animals; D002455:Cell Division; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D066298:In Vitro Techniques; D007938:Leukemia / Q000188:drug therapy* / Q000473:pathology; D007939:Leukemia L1210 / Q000188:drug therapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D008466:Mechlorethamine / Q000627:therapeutic use; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D051379:Mice; D008938:Mitosis; D009603:Nitroso Compounds / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D013936:Thymidine; D013997:Time Factors; D014316:Tritium; D014747:Vinblastine / Q000627:therapeutic use; D014750:Vincristine / Q000627:therapeutic use
D000813:Anilides; D004273:DNA, Neoplasm; D009603:Nitroso Compounds; D003561:Cytarabine; D014316:Tritium; D008466:Mechlorethamine; D014750:Vincristine; D014747:Vinblastine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D005472:Fluorouracil; D011241:Prednisone; D013936:Thymidine; D006918:Hydroxyurea; D008727:Methotrexate